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Abstract 
Objective: Rapid, reliable, and affordable detection of Brucella species via the molecular methods remains a chal‑
lenge. In recent years, loop‑mediated isothermal amplification (LAMP) is a functional nucleic acid amplification 
technique offering a substitute to polymerase chain reaction (PCR). So, we compared the LAMP assay with the con‑
ventional PCR for the identification of common Brucella species in Iran. In this study, LAMP assay was comprehensively 
evaluated against the common PCR method. A group of specific LAMP primers were used to amplify a highly specific 
fragment from the sequence of the Brucella abortus, bcsp31 gene. Sensitivity and specificity values of tests were done 
with a set of 78 (50 Brucella and 28 non‑Brucella) strains.
Results: A dilution series of B. abortus DNA indicated that the LAMP reaction could reliably detect 10 (fg/µl) DNA 
target copies per reaction within 36 min, which is 10 times greater than the PCR assay. In summary, we conclude 
that LAMP assay provide accurate and fast test results to identify of common Brucella species in low‑complexity labs, 
mainly in low and lower middle income countries.
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Introduction
Brucella species are small, coccobacilli, Gram-nega-
tive, absolute aerobic and non-moving bacteria which 
causes undulant fever in humans and leads to abortion 
and infertility in animals [1]. Brucella can be transmit-
ted to humans through direct contact with animals or 
their products that are contaminated with these bacteria 
[2]. Brucella genus has six species that cannot be distin-
guished from each other due to the close phenotypic and 
antigenic similarities with conventional microbiological 
methods [3, 4]. From these six species, [B. abortus, B. 
melitensis, B. suis and B. canis] generally causes human 
infection [5]. About half a million cases of human bru-
cellosis are reported annually which is estimated to be 
10–25% less than the real number of the 1997 world 
health organization (WHO) report [6]. The centers for 
disease control and prevention strategic planning group 
as listed B. abortus, B. melitensis, B. suis as category B 
biothreat agents [5, 7]. There are currently three main 
methods for the identification of brucellosis [8]. Over-
all, in human brucellosis, isolation of the bacterium by 
blood culture is considered as the gold standard for lab-
oratory diagnosis, but the procedure is time consuming 
[9, 10], and has a low sensitivity in the range of 15–70% 
depending on the bacterial species and infectious phase 
[11]. On the other hand, this method, due to class III 
biosafety of Brucella is very dangerous and pollutant for 
laboratory personnel [12, 13]. Serological examinations 
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are not satisfactory. One such example is that they have 
low sensitivity, due to the structural similarity of Brucella 
lipopolysaccharide (LPS) with other Gram-negative bac-
teria [3, 14]. Nucleic acid amplification tests (NAATs), 
such as the polymerase chain reaction (PCR) with high 
sensitivity and specificity have been developed to detect 
Brucella DNA in human specimens [15, 16, 17]. PCR and 
other molecular techniques have their own disadvan-
tages; for example; most molecular techniques require a 
thermal cycler machine, which is not feasible for labora-
tories in deprived areas such as rural laboratories [18]. 
The LAMP system has been developed as a new diag-
nostic technique which could replicate the target DNA 
without the need for a thermal cycler. In this method 
with unique Bst DNA polymerase large fragment char-
acteristics such as autoclaving and strand displacement, 
it became possible to eliminate the thermal cycler and 
replaced it with thermal block or bain-marie, it was also 
possible to see the results by visual inspection. because 
of turbidity generated in positive samples [19, 20]. This 
technique has already been evaluated and tested to iden-
tify and detect different bacteria and viruses and its high 
sensitivity and specificity have been proven [21–24]. So, 
we compared the LAMP assay with the conventional 




Bacterial strains and sample processing
In this study, to standardize the LAMP protocols, 78 bac-
terial strains including 50 Brucella and 28 non-Brucella 
strains were analyzed (details mentioned in Table  1). 
Brucella strains was cultured in a BSL2 laboratory on 
5% sheep blood agar medium (Merck, Germany) and 
on Brucella agar medium with 5% sheep blood (Merck, 
Germany) under 5%  CO2 in an-anaerobic jar for 36 h at 
37 ºC. Other non-Brucella strains were cultured in tryp-
ticase soy agar (Merck, Germany) and deleted replasing 
supplemented with 5% sheep blood agar for 18 h at 37 ºC.
DNA extraction procedures
Briefly, a loopful of colonies were aseptically collected 
from the plates and suspended in 5  mL pf phosphate 
buffered saline (PBS) until its opacity reaches #2 McFar-
land standard turbidity. After vortexing, genomic DNA of 
strains were extracted with the High Pure PCR Template 
Preparation Kit (Roche, Germany), according to the man-
ufacturer’s instructions. The absorbance ratio (A260/280) 
is used to evaluate the purity of DNA.
Primers
We tried to detect the same gene in each two techniques 
for minimization of the variables, so the bcsp31 gene 
selected for the detection in both techniques. The prim-
ers sequences used for LAMP and PCR was shown in 
Table2.
Conventional PCR
The PCR assay was carried out as previously described by 
Baily et al. [15]. Amplification targeting bcsp31 gene was 
performed in a Techne TC-512 thermal cycler (Eppen-
dorf, Hamburg, Germany) according to the conditions 
mentioned in Table 3.
Table 1 Bacterial strains used in this study and the results of PCR and LAMP amplification
Strains Species (biovar) No. of strains Source LAMP results PCR results
B. abortus 1 1 S99 (Reference)  +  + 
B. abortus 1 1 S19 (vaccine strain)  +  + 
B. abortus 2 1 Clinical isolate  +  + 
B. abortus 3 18 Clinical isolate  +  + 
B. abortus 3 7 Animal isolate  +  + 
B. melitensis 1 1 16 M (ATCC23456)  +  + 
B. melitensis 1 13 Clinical isolate  +  + 
B. melitensis 1 8 Animal isolate  +  + 
Escherichia coli O157:H7 4 Clinical isolate − −
Staphylococcus aureus 4 Clinical isolate − −
Vibrio cholerae O1 4 Clinical isolate − −
Klebsiella pneumoniae 4 Clinical isolate − −
Acinetobacter baumannii 4 Clinical isolate − −
Pseudomonas 4 Clinical isolate − −
Shigella flexineri 4 Clinical isolate − −
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LAMP reaction optimization
We used six primers for LAMP assay in this study, 
LAMP outer primers (F3 and B3), forward inner 
primer (FIP) and backward inner primer (BIP), which 
identify four different fragments on the DNA tar-
get sequence, and two loop primers (LF and LB) to 
increase proliferation speed. Also, modifying con-
centration of reaction components and conditions 
such as reaction time (20–50  min), amplification tem-
peratures (61–67  °C), concentration of dNTPs (0 to 
2 mM), MgSO4 (0–6.4 mM) and Bst polymerase (2–12 
Unit) were chosen to assist in optimizing LAMP pro-
cedure in targeting  the  bcsp31 gene. The optimized 
reaction mixture contained 5  pmol  l−1 each of outer 
primers (F3 and B3), 40  pmol  l−1 each of inner prim-
ers (FIP and BIP), 20 pmol l−1 each of loop primers (LF 
and LB), 1.4  mmol  l−1 each deoxynucleoside triphos-
phates, 0.8  mol  l−1betain (Sigma, B0300,St. Louis, 
USA), 20 mmol l−1Tris–HCl, 10 mmol l−1 (NH4)2SO4, 
10  mmol  l−1KCl, 8  mmol  l−1 MgSO4, 0.1% Triton 
X-100, 8 units of Bst polymerase (New EnglandBio-
labs, M0275S, Beverly, USA) and 2 µl of genomic DNA. 
Before adding the Bst DNA polymerase, reaction 
mixture was heated up at 95  °C for 5  min in a Ther-
moblock heat system, and then cooled on ice for 10 min 
to provide an appropriate environment for adding Bst. 
Subsequently, the mixture was incubated at 63  ºC for 
35 min and then, tubes heated at 95 °C for 2 min to stop 
the reaction. Five microliters of the product were sub-
jected to 2% agarose gel electrophoresis.
Results
All the 50 strains of 4 serotypes of Brucella were shown 
to be positive by LAMP.
Conventional PCR
The PCR was performed on 78 species, and a 223  bp 
bands was observed in all of Brucella spp, on 1.5% aga-
rose gel. Whereas, no band was seen in other species. 
The sensitivity and specificity of the primers used in this 
study have been evaluated by Baily et al. [15]. The detec-
tion limit for the PCR assay in the mentioned conditions 
was 100 fg.
Establishment of BCSP31 LAMP and product confirmation
In this research, we tried our best to minimize the Bru-
cella DNA amplification time in the LAMP assay. So, in 
deprived areas of Iran, laboratories can measure human 
or animal contamination in the shortest time with the 
protocol described in this study. By changing the LAMP 
assay reaction [termination step protocol from 80  °C in 
5 min to 95 °C in 2 min] we obtained similar results. Thus 
we replaced the new modified protocol with the general 
protocol. To set up and optimization, we used B. meliten-
sis 16  M (ATCC 23456) DNA as template. The LAMP 
assay successfully amplified  the target (bcsp31 gene) at 
63ºC in 35 min. The well-defined bands patterns, which is 
a trait of the LAMP reaction and shows the forming DNA 
stem–loop with inverted repeats of the target sequence 
[19] was checked using gel electrophoresis method.
Sensitivity of LAMP reaction
After adjusting the best conditions for the LAMP reac-
tion, the lower detection limit of the LAMP was meas-
ured using tenfold serial dilution (initial concentration of 
10 ng) of the DNA samples for bcsp31 gene. Ladder-like 
pattern on 2% agarose gel was identified by target DNA 
of as low as 10  fg. Also, sensitivity of minimal detecta-
ble rate of LAMP test in compare with PCR is shown in 
Additional file  1: Figure S1. As shown in the figure, the 
minimal detectable rate of the LAMP test is 10  fg/µl. 
Therefore, it can be concluded that the minimal detect-
able rate of LAMP test is 10-times higher than PCR and 
can be detect a less amount of bacterial genome in the 
sample. So, LAMP test is more sensitive than PCR.
Table 2 Sequences of  primers used for  LAMP and  PCR 
assay
Assay Primer Sequence Amplicon 
size (bp)
Reference
LAMP F3 5′‐GCT TTA CGC AGT CAG ACG T‐3′ 189 [25]
B3 5′‐GCT CAT CCA GCG AAA CGC ‐3′
FIP 5′‐AGG CGC AAA TCT TCC ACC TTG 
CGC CTA TTG GGC CTA TAA CGG ‐3′
BIP 5′‐GGC GAC GCT TTA CCC GGA AAT 
TCA GGT CTG CGA CCG AT‐3′
LF 5′‐CCT TGC CAT CAT AAA GGC C‐3′
LB 5′‐CGT AAG GAT GCA AAC ATC AA‐3′
PCR B4 5′‑TGG CTC GGT TGC CAA TAT CAA‑3′ 223 [15]
B5 5′‑CGC GCT TGC CTT TCA GGT CTG‑3′
Table 3 PCR condition for bcsp31 template
Feature Temperature (°C) Time
Gene (bcsp31)
 Initial denaturation 95 5 min
 Denaturation 95 60 s
 Annealing 65 30 s
 Extension 72 60 s
 Final extension 72 6 min
 Cycle 35 –
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Naked‑eye detection of positive bcsp31 LAMP amplification
Under situations where detection and urgent care 
requires rapid response, it is greatly favorable for specify 
all positive samples as soon as possible. This is one of the 
advantages of the LAMP assay versus PCR. To achieve 
this important, the products inside the 0.2  mL micro-
tubes were placed under white light and the turbidity 
caused by magnesium pyrophosphate  (Mg2P2O7) in posi-
tive samples was observed with the naked eye. Products 
were also observed by adding 1 to 100 diluted fluorescent 
detection reagent (SYBR Green I, S9430, Sigma-Aldrich, 
Germany) under normal, and UV light. There was no dif-
ference between the LAMP results detected by fluores-
cence and turbidity.
Assay specificity through several types of bacterial spp
To assess the specificity of the LAMP reaction, all 78 bac-
terial strains were tested by bcsp31gene-based LAMP 
assay. The results of this assay are shown in Table 1; the 
test result for non-Brucella species was negative. Our 
results showed that the P-1 primer set successfully and 
specifically amplified bcsp31 gene of Brucella species 
in vaccine strains, clinical and animal isolates. Whereas 
other non-Brucella strains did not show any turbidity, 
fluorescent and any bands on the agarose gel electropho-
resis under equal conditions.
Discussion
This is the primary description on the employment 
of LAMP to the identification of common species of 
Brucella based on the bcsp31 gene in Iran. Brucellosis 
remains a neglected illness in the developing countries. 
Due to the high prevalence of Brucellosis early diagnosis 
in conjugation with timely medical intervention is neces-
sary to prevention and control of the infectious disease 
[26]. The Rose Bengal test (RBT) as a easy method for 
the identification of specific antibodies against Brucella. 
However, their fruitfulness is restricted via elevated 
frequencies of  Brucella‐specific antibody titer in high-
brucellosis burden countries and it low sensitivity at 
acute phase of disease [27, 28]. Furthermore, the growth 
of Brucella spp. is time consuming and complex, subse-
quently bacteriological culture and microscopic exami-
nation are cumbersome and difficult [29]. Our major 
purpose of this work was to assess and compare the 
diagnostic capabilities of two different molecular detec-
tion methods, i.e. LAMP and PCR techniques and to 
find out whether the LAMP technique is a good alterna-
tive to the PCR. We used direct culture test as the “Gold 
standard” for the preparation of fresh DNA and the uni-
formization of the terms of the techniques. The LAMP 
assay is advantageous in compare to the PCR, because 
of its feasible, easy construction, quick answer and vis-
ual recognition. Its simplicity and using low-cost equip-
ment, including laboratory water bath that prepare a 
stable heat of 63 °C is acceptable for the test. Compared 
to the PCR, the LAMP results is straightly observable 
with the unaided eye negating the necessity for electro-
phoretic investigation [19]. Moreover, the LAMP assay 
unlike other molecular techniques does not require spe-
cial and expensive devices such as thermal cycler and 
can be performed in low-budget labs in deprived areas, 
which there is a probability of an outbreak or expose to 
brucellosis. Characteristics evaluated for the comparison 
of two techniques in order to overcome one over another 
in the studies includes the duration of the amplification, 
the sensitivity, specificity of the technique and the limit 
of detection. The PCR technique lasted approximately 
90  min and 100  fg of Brucella DNA was successfully 
completed. In addition, non-specific responses to mul-
tiple negative controls were not observed. In the LAMP 
assay, 10  fg of  Brucella  DNA was favorably amplified 
during 35  min and, the primers used did not have any 
non-specific reaction to bacterial DNA that was used as 
negative controls. In comparison of these two assays, the 
PCR took about 90  min, while the  Brucella  LAMP can 
be finished within 35 min also according to the limit of 
detection in two assays the sensitivity of the LAMP assay 
was 10 times higher to that of PCR. About the specificity 
of the two techniques, each of the two techniques does 
not have any nonspecific reaction with multiple negative 
controls and their specificity was almost equal. The Bru-
cella LAMP technique examined in the work is a quick, 
highly specific and sensitive method that can be substi-
tuted for PCR assays in the low-budget labs of Iran and 
are able to identify native strains of Brucella in Iran. This 
is a suitable system for peripheral laboratories to diag-
nosis and investigation of human brucellosis in endemic 
setting.
Limitations
The assay should be evaluated using blood or other clini-
cal specimens from infected patients.
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Additional file 1: Figure S1. Sensitivity of minimal detectable rate of 
LAMP test in compare with PCR. (A); the minimal detectable rate of 
Brucella DNA in PCR technique is 100 fg / μl, (B); detection of 10 fg / μl 
bacteria genome in LAMP test. M; 100 bp DNA size marker (SinaClon 
Bioscience Co, Iran), C‑ (negative control).
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